1. Home
  2. OPTX vs CTSO Comparison

OPTX vs CTSO Comparison

Compare OPTX & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTX
  • CTSO
  • Stock Information
  • Founded
  • OPTX 1981
  • CTSO 1997
  • Country
  • OPTX United States
  • CTSO United States
  • Employees
  • OPTX N/A
  • CTSO N/A
  • Industry
  • OPTX Blank Checks
  • CTSO Medical/Dental Instruments
  • Sector
  • OPTX Finance
  • CTSO Health Care
  • Exchange
  • OPTX Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • OPTX 51.9M
  • CTSO 57.2M
  • IPO Year
  • OPTX N/A
  • CTSO N/A
  • Fundamental
  • Price
  • OPTX $0.88
  • CTSO $0.93
  • Analyst Decision
  • OPTX
  • CTSO Strong Buy
  • Analyst Count
  • OPTX 0
  • CTSO 3
  • Target Price
  • OPTX N/A
  • CTSO $4.67
  • AVG Volume (30 Days)
  • OPTX 49.6K
  • CTSO 154.0K
  • Earning Date
  • OPTX 11-14-2024
  • CTSO 11-07-2024
  • Dividend Yield
  • OPTX N/A
  • CTSO N/A
  • EPS Growth
  • OPTX 81.79
  • CTSO N/A
  • EPS
  • OPTX 0.01
  • CTSO N/A
  • Revenue
  • OPTX $28,126,356.00
  • CTSO $37,739,531.00
  • Revenue This Year
  • OPTX N/A
  • CTSO $13.09
  • Revenue Next Year
  • OPTX N/A
  • CTSO $15.68
  • P/E Ratio
  • OPTX $72.91
  • CTSO N/A
  • Revenue Growth
  • OPTX N/A
  • CTSO 1.80
  • 52 Week Low
  • OPTX $0.88
  • CTSO $0.70
  • 52 Week High
  • OPTX $8.39
  • CTSO $2.15
  • Technical
  • Relative Strength Index (RSI)
  • OPTX 31.43
  • CTSO 42.78
  • Support Level
  • OPTX $0.88
  • CTSO $0.71
  • Resistance Level
  • OPTX $1.59
  • CTSO $0.97
  • Average True Range (ATR)
  • OPTX 0.11
  • CTSO 0.10
  • MACD
  • OPTX -0.07
  • CTSO 0.01
  • Stochastic Oscillator
  • OPTX 4.24
  • CTSO 54.55

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: